In preparation for congressional hearings regarding the reauthorization of the Health Research Extension Act of 1985, Dr. Armand Hammer, Chairman of the President’s Cancer Panel, requested the Director of the National Cancer Institute (NCI) to prepare this report on the special authorities and responsibilities provided specifically to the Director, NCI under Part C Subpart 1 of the Act. This Subpart is commonly referred to as the National Cancer Act. NCI published the report in April 1988.